Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
Molecular and Clinical Oncology
|
May 23, 2017
Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target
Heike Loeser, Dirk Waldschmidt, Fabian Kuetting, et al.
Journal of Thoracic Disease
|
February 19, 2019
Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology
Christina Alidousty, Till Baar, Carina Heydt, et al.
Molecular and Clinical Oncology
|
August 9, 2020
Multiple recurrent follicular dendritic cell sarcoma: A case report
Lara Schorn, Julian Lommen, Rita Depprich, et al.
Human Pathology
|
September 14, 2025
GNAQ-/GNA14-mutated hepatic vascular malformation with capillary proliferation in adults and children
Anne Kristin Fischer, Carina Heydt, Janna Siemanowski-Hrach, et al.
Journal of Clinical Pathology
|
April 13, 2017
Use of the GeneReader NGS System in a clinical pathology laboratory: a comparative study
Ulrike Koitzsch, Carina Heydt, Hans Attig, et al.
Virchows Archiv : an International Journal of Pathology
|
November 18, 2022
Incidental FOXL2 mutated adult granulosa cell tumour of the ovary with thecoma-like foci
Anne Kristin Fischer, Birgid Schömig-Markiefka, Carina Heydt, et al.
Cancers
|
December 10, 2021
Mismatch Repair Deficiency and Somatic Mutations in Human Sinonasal Tumors
Lena Hieggelke, Carina Heydt, Roberta Castiglione, et al.
Computational and Structural Biotechnology Journal
|
November 26, 2019
Comparison of <i>in situ</i> and extraction-based methods for the detection of <i>MET</i> amplifications in solid tumors
Carina Heydt, Ann-Kathrin Becher, Svenja Wagener-Ryczek, et al.
Cancers
|
October 27, 2022
Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations
Gabriele Gamerith, Marcel Kloppenburg, Finn Mildner, et al.
Oncotarget
|
June 4, 2015
FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro
Helen Künstlinger, Jana Fassunke, Hans-Ulrich Schildhaus, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
Molecular and Clinical Oncology
|
May 23, 2017
Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target
Heike Loeser, Dirk Waldschmidt, Fabian Kuetting, et al.
Journal of Thoracic Disease
|
February 19, 2019
Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology
Christina Alidousty, Till Baar, Carina Heydt, et al.
Molecular and Clinical Oncology
|
August 9, 2020
Multiple recurrent follicular dendritic cell sarcoma: A case report
Lara Schorn, Julian Lommen, Rita Depprich, et al.
Human Pathology
|
September 14, 2025
GNAQ-/GNA14-mutated hepatic vascular malformation with capillary proliferation in adults and children
Anne Kristin Fischer, Carina Heydt, Janna Siemanowski-Hrach, et al.
Journal of Clinical Pathology
|
April 13, 2017
Use of the GeneReader NGS System in a clinical pathology laboratory: a comparative study
Ulrike Koitzsch, Carina Heydt, Hans Attig, et al.
Virchows Archiv : an International Journal of Pathology
|
November 18, 2022
Incidental FOXL2 mutated adult granulosa cell tumour of the ovary with thecoma-like foci
Anne Kristin Fischer, Birgid Schömig-Markiefka, Carina Heydt, et al.
Cancers
|
December 10, 2021
Mismatch Repair Deficiency and Somatic Mutations in Human Sinonasal Tumors
Lena Hieggelke, Carina Heydt, Roberta Castiglione, et al.
Computational and Structural Biotechnology Journal
|
November 26, 2019
Comparison of <i>in situ</i> and extraction-based methods for the detection of <i>MET</i> amplifications in solid tumors
Carina Heydt, Ann-Kathrin Becher, Svenja Wagener-Ryczek, et al.
Cancers
|
October 27, 2022
Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations
Gabriele Gamerith, Marcel Kloppenburg, Finn Mildner, et al.
Oncotarget
|
June 4, 2015
FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro
Helen Künstlinger, Jana Fassunke, Hans-Ulrich Schildhaus, et al.
Page
of 6